2m 2m 2m 2m 2m 2m 2m
IMMUNITYBIO (IBRX)
NASDAQ
$7.78-$0.01 (-0.19%)
Price as of Aug 21, 2026 7:59 PM EDT- $8.3BMarket Cap
- 237.23%1-Year Change
- BiotechnologyIndustry
IMMUNITYBIO (IBRX)
$7.78-$0.01 (-0.19%)
IBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.79 | ||
Change | -$0.05 (-0.64%) | ||
Open | $7.85 | ||
High | $7.95 | ||
Low | $7.60 | ||
Previous Close | $7.84 | ||
Volume | 7,619,706 | ||
30-Day Average Volume | 8,691,071 | ||
1-Week Change | 2.91% | ||
1-Month Change | -3.47% | ||
1-Year Change | 237.23% | ||
3-Year Change | 373.56% | ||
5-Year Change | -22.10% | ||
Fundamentals | |||
Shares Outstanding | 1.1B | ||
Total Assets | $628.5M | ||
Market Cap | $8.3B | ||
Enterprise Value | $9.4B | ||
Period: QTR TTM FY | |||
Revenue | $50.7M | ||
Net Income | -$230.4M | ||
Free Cash Flow | -$70.0M | ||
EBIT | -$213.2M | ||
EBITDA | -$208.8M | ||
Net Working Capital | $362.3M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 185 | ||
P/B | -8 | ||
P/E | -35 | ||
PEG | -1 | ||
Price/Free Cash Flow | -118 | ||
Price/Operating Cash Flow | -124 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue